We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

42 hedge funds and large institutions have $21.3M invested in Abeona Therapeutics in 2015 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 3

599% more call options, than puts

Call options by funds: $538K | Put options by funds: $77K

250% more funds holding

Funds holding: 12 → 42 (+30)

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

61% more capital invested

Capital invested by funds: $13.2M → $21.3M (+$8.1M)

Holders
42
Holders Change
+30
Holders Change %
+250%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
33
Increased
6
Reduced
2
Closed
3
Calls
$538K
Puts
$77K
Net Calls
+$461K
Net Calls Change
+$461K

Top Buyers

Rank Fund Capital Flow
1
KCM
Knoll Capital Management
Florida
+$6.89M
2
SFM
Soros Fund Management
New York
+$4.01M
3
BFA
BlackRock Fund Advisors
California
+$1.65M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.44M
5
Morgan Stanley
Morgan Stanley
New York
+$720K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$4.69M
2
OIM
Oracle Investment Management
Connecticut
-$4.24M
3
SM
Sabby Management
Florida
-$3.77M
4
DM
Deerfield Management
New York
-$1.1M
5
Creative Planning
Creative Planning
Kansas
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$6.88M +$6.89M +45,867 +538%
SFM
2
Soros Fund Management
New York
$4.64M +$4.01M +26,667 +267%
PA
3
Perceptive Advisors
New York
$2.38M -$4.69M -31,200 -62%
BFA
4
BlackRock Fund Advisors
California
$1.39M +$1.65M +10,979 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.21M +$1.44M +9,581 New
SM
6
Sabby Management
Florida
$808K -$3.77M -25,124 -80%
Morgan Stanley
7
Morgan Stanley
New York
$611K +$720K +4,792 +11,980%
CT
8
Cambridge Trust
Massachusetts
$331K +$393K +2,617 New
BIT
9
BlackRock Institutional Trust
California
$325K +$386K +2,570 New
State Street
10
State Street
Massachusetts
$316K +$375K +2,499 New
CS
11
Credit Suisse
Switzerland
$293K +$348K +2,314 New
TI
12
Trexquant Investment
Connecticut
$247K +$294K +1,960 New
Millennium Management
13
Millennium Management
New York
$218K +$190K +1,268 +281%
BIM
14
BlackRock Investment Management
Delaware
$192K +$228K +1,521 New
TCIM
15
TIAA CREF Investment Management
New York
$171K +$202K +1,348 New
Bank of New York Mellon
16
Bank of New York Mellon
New York
$132K +$157K +1,047 New
WMSA
17
Weiss Multi-Strategy Advisers
New York
$127K +$150K +1,000 New
KA
18
KLCM Advisors
Wisconsin
$111K +$131K +874 New
RCM
19
Rotella Capital Management
Washington
$108K +$128K +852 New
TRCT
20
Tower Research Capital (TRC)
New York
$102K +$119K +794 +4,671%
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$95K +$113K +755 New
VKH
22
Virtu KCG Holdings
New York
$94K +$112K +743 New
TA
23
Teachers Advisors
New York
$93K +$111K +738 New
Northern Trust
24
Northern Trust
Illinois
$80K +$95.5K +636 New
AllianceBernstein
25
AllianceBernstein
Tennessee
$78K +$93.1K +620 New
1
2

ABEO Hedge Fund Activity: Q2 2015 in Review

42 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q2 2015, worth a combined $21.3M — up 61% from $13.2M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ABEO positions and 3 closed out — a net gain of 30 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Knoll Capital Management, adding an estimated $6.89M. The largest seller was Perceptive Advisors, cutting an estimated $4.69M.

  • 42 institutional investors held Abeona Therapeutics (ABEO) as of Q2 2015, up from 12 in Q1 2015.
  • Funds reported $21.3M of Abeona Therapeutics stock for Q2 2015, up 61% quarter-over-quarter.
  • 33 funds opened new Abeona Therapeutics positions in Q2 2015 and 3 closed out, a net change of +30 holders.
  • The largest Abeona Therapeutics buyer in Q2 2015 was Knoll Capital Management, an estimated $6.89M added.
  • The largest Abeona Therapeutics seller in Q2 2015 was Perceptive Advisors, an estimated $4.69M sold.

Based on aggregated 13F filings for Q2 2015.